✦ LIBER ✦

A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer

✍ Scribed by Robert Pelley; Ram Ganapathi; Laura Wood; Lisa Rybicki; Denise McLain; G. Thomas Budd; David Peereboom; Thomas Olencki; Ronald M. Bukowski; G. Thomas Budd

Publisher: Springer
Year: 2000
Tongue: English
Weight: 76 KB
Volume: 46
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800000139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of pyrazoloacridine in pa

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma

✍ Mark M. Zalupski; Philip A. Philip; Patricia LoRusso; Anthony F. Shields 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 101 KB

Phase II trial of edatrexate in patients

Phase II trial of edatrexate in patients with metastatic colorectal cancer

✍ Gerald H. Clamon; Charles E. Riggs; Robert Dreicer; Raymond J. Hohl 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 242 KB

Suramin in patients with metastatic colo

Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II Study

✍ Alfredo Falcone; Elisabetta Pfanner; Claudia Cianci; Romano Danesi; Isa Brunetti 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 2 views

Phase II study of ionidamine in patients

Phase II study of ionidamine in patients with metastatic breast cancer

✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi

Fluorodeoxyuridine with continuous leuco

Fluorodeoxyuridine with continuous leucovorin infusion a phase ii clinical trial in patients with metastatic colorectal cancer

✍ Robert D. Levin; John H. Gordon 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

A phase II study of irinotecan in combin

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer

✍ Takeshi Kato; Hideyuki Mishima; Masakazu Ikenaga; Kouhei Murata; Hideyuki Ishida 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB